U.S. Army Pays $1.9 Billion for Additional 100 Million Doses SARS-COVID Vaccine

Moderna US Inc., Cambridge, MA, was awarded a $1.9 billion contract modification for an additional 100 million filled drug production doses of SARS-CoV-2 mRNA-1273 vaccine utilizing Option 1 and acetate efforts on the base and option.